RxDoctor Payments Data

Scott Dessain

Hematology · Philadelphia, PANPI 1326061508

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,290 of the $79,122 with a category attached, or 72.4%. Genentech USA, Inc. accounts for 91.2% of it on its own, with 48 other manufacturers making up the rest. Reporting peaked in 2019 at $73,492 and has fallen 97.9% since, to $1,576 in 2025. Among hematology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,122in general payments, 2019–2025

Across 323 payments — averaging $244.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$72K
  • AstraZeneca$1K
  • Novartis$632
  • Jazz Pharmaceuticals Inc.$521
  • Merck$471
  • Mirati Therapeutics, Inc.$341
  • plus $4K from 43 others

What the payments were for

  • Speaking & faculty fees$57,29072%
  • Travel & lodging$13,56517%
  • Food & beverage$8,16710%
  • Education$1000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,122 in reported general payments places this provider in the 95th percentile of 64 hematology providers in Pennsylvania.

See all hematology providers in Pennsylvania

Other hematology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →